Literature DB >> 19262571

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Kornelia Polyak1, Robert A Weinberg.   

Abstract

Transitions between epithelial and mesenchymal states have crucial roles in embryonic development. Emerging data suggest a role for these processes in regulating cellular plasticity in normal adult tissues and in tumours, where they can generate multiple, distinct cellular subpopulations contributing to intratumoural heterogeneity. Some of these subpopulations may exhibit more differentiated features, whereas others have characteristics of stem cells. Owing to the importance of these tumour-associated phenotypes in metastasis and cancer-related mortality, targeting the products of such cellular plasticity is an attractive but challenging approach that is likely to lead to improved clinical management of cancer patients.

Entities:  

Mesh:

Year:  2009        PMID: 19262571     DOI: 10.1038/nrc2620

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  86 in total

Review 1.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

3.  Global loss of imprinting leads to widespread tumorigenesis in adult mice.

Authors:  Teresa M Holm; Laurie Jackson-Grusby; Tobias Brambrink; Yasuhiro Yamada; William M Rideout; Rudolf Jaenisch
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

Review 4.  Transitions between epithelial and mesenchymal states in development and disease.

Authors:  Buzz Baum; Jeffrey Settleman; Margaret P Quinlan
Journal:  Semin Cell Dev Biol       Date:  2008-02-09       Impact factor: 7.727

5.  A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition.

Authors:  Manuel Beltran; Isabel Puig; Cristina Peña; José Miguel García; Ana Belén Alvarez; Raúl Peña; Félix Bonilla; Antonio García de Herreros
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

6.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

7.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.

Authors:  O Aguilera; M F Fraga; E Ballestar; M F Paz; M Herranz; J Espada; J M García; A Muñoz; M Esteller; J M González-Sancho
Journal:  Oncogene       Date:  2006-02-20       Impact factor: 9.867

Review 8.  Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins.

Authors:  Jennifer M Bailey; Pankaj K Singh; Michael A Hollingsworth
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

9.  The Wnt antagonist sFRP1 in colorectal tumorigenesis.

Authors:  Germaine M Caldwell; Carolyn Jones; Karl Gensberg; Shamem Jan; Robert G Hardy; Philip Byrd; Shaheen Chughtai; Yvonne Wallis; Glenn M Matthews; Dion G Morton
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

Review 10.  Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.

Authors:  Michèle Sabbah; Shahin Emami; Gérard Redeuilh; Sylvia Julien; Grégoire Prévost; Amazia Zimber; Radia Ouelaa; Marc Bracke; Olivier De Wever; Christian Gespach
Journal:  Drug Resist Updat       Date:  2008-08-20       Impact factor: 18.500

View more
  1492 in total

1.  Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement.

Authors:  Rebecca A Whipple; Michael A Matrone; Edward H Cho; Eric M Balzer; Michele I Vitolo; Jennifer R Yoon; Olga B Ioffe; Kimberly C Tuttle; Jing Yang; Stuart S Martin
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.

Authors:  Runlin Shi; Haibing Xiao; Tao Yang; Lei Chang; Yuanfeng Tian; Bolin Wu; Hua Xu
Journal:  Front Med       Date:  2014-11-03       Impact factor: 4.592

3.  Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.

Authors:  Jason I Herschkowitz; Wei Zhao; Mei Zhang; Jerry Usary; George Murrow; David Edwards; Jana Knezevic; Stephanie B Greene; David Darr; Melissa A Troester; Susan G Hilsenbeck; Daniel Medina; Charles M Perou; Jeffrey M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-01       Impact factor: 11.205

4.  CD95 and CD95L promote and protect cancer stem cells.

Authors:  Paolo Ceppi; Abbas Hadji; Frederick J Kohlhapp; Abhinandan Pattanayak; Annika Hau; Xia Liu; Huiping Liu; Andrea E Murmann; Marcus E Peter
Journal:  Nat Commun       Date:  2014-11-04       Impact factor: 14.919

Review 5.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

6.  Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells.

Authors:  Kamola Saydaminova; Robert Strauss; Min Xie; Jiri Bartek; Maximilian Richter; Ruan van Rensburg; Charles Drescher; Anja Ehrhardt; Sheng Ding; André Lieber
Journal:  Cancer Biol Ther       Date:  2016-08-30       Impact factor: 4.742

7.  MiR-200c suppresses the migration of retinoblastoma cells by reversing epithelial mesenchymal transition.

Authors:  Xiao-Lei Shao; Yao Chen; Ling Gao
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

8.  A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?

Authors:  Alireza Mirzaei; Gholamreza Tavoosidana; Afshin Abdi Rad; Farhad Rezaei; Masoumeh Tavakoli-Yaraki; Azade Amini Kadijani; Ehsan Khalili; Zahra Madjd
Journal:  Tumour Biol       Date:  2015-09-17

9.  Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling.

Authors:  Sushil Kumar; Ratnesh Kumar Srivastava; Snahlata Singh; Ajeya Nandi; Gatha Thacker; Hemma Murali; Sabrina Kim; Mary Baldeon; John Tobias; Mario Andres Blanco; Rizwan Saffie; M Raza Zaidi; Satrajit Sinha; Luca Busino; Serge Y Fuchs; Rumela Chakrabarti
Journal:  Nat Cell Biol       Date:  2020-04-13       Impact factor: 28.824

10.  PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal transition.

Authors:  Siming Yu; Linna Li; Wei Tian; Dan Nie; Wei Mu; Fang Qiu; Yu Liu; Xinghan Liu; Xiaofeng Wang; Zhimin Du; Wen-Feng Chu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2018-06-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.